Ornidazole
- CAS No.
- 16773-42-5
- Chemical Name:
- Ornidazole
- Synonyms
- OPSS;1-Chloro-3-(2-Methyl-5-nitro-1H-iMidazol-1-yl)propan-2-ol;tiberal;alpha-(chlormethyl)-2-methyl-5-nitro-imidazol-1-aethanol;Ornidazol a-(ChloroMethyl)-2-Methyl-5-nitro-1H-iMidazole-1-ethanol;Madelen;Ornidal;ro7-0207;NSC 95075;Ornidazol
- CBNumber:
- CB5735895
- Molecular Formula:
- C7H10ClN3O3
- Molecular Weight:
- 219.63
- MOL File:
- 16773-42-5.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/8/2 18:12:07
Melting point | 85-90°C |
---|---|
Boiling point | 443.2±40.0 °C(Predicted) |
Density | 1.6545 (rough estimate) |
refractive index | 1.6000 (estimate) |
storage temp. | Sealed in dry,Room Temperature |
solubility | Soluble in ethanol at 50mg/ml |
pka | 2.4 ± 0.1(at 25℃) |
form | Solid |
color | Crystals from toluene |
λmax | 276nm(H2SO4 aq.)(lit.) |
Merck | 14,6872 |
InChIKey | IPWKIXLWTCNBKN-UHFFFAOYSA-N |
CAS DataBase Reference | 16773-42-5(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H302 | |||||||||
Precautionary statements | P264-P270-P301+P312a-P330-P501a | |||||||||
Hazard Codes | Xn | |||||||||
Risk Statements | 22 | |||||||||
Safety Statements | 36 | |||||||||
WGK Germany | 3 | |||||||||
RTECS | NI5460000 | |||||||||
HS Code | 2933.29.4300 | |||||||||
HazardClass | IRRITANT | |||||||||
Toxicity | LD50 in rats, mice (mg/kg): 1780, 1420 orally (Grunberg); LD50 in mice (mg/kg): >2000 orally, >2000 i.p. (Hoffer, Grunberg) | |||||||||
NFPA 704 |
|
Ornidazole price More Price(3)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | O5879 | Ornidazole analytical standard | 16773-42-5 | 5G | ₹9244.55 | 2022-06-14 | Buy |
TCI Chemicals (India) | O0417 | Ornidazole | 16773-42-5 | 5G | ₹5100 | 2022-05-26 | Buy |
TCI Chemicals (India) | O0417 | Ornidazole | 16773-42-5 | 25G | ₹8700 | 2022-05-26 | Buy |
Ornidazole Chemical Properties,Uses,Production
Description
Ornidazole is an orally bioavailable 5-nitroimidazole derivative with antibacterial and antiprotozoal activities. Ornidazole inhibits the growth of clinical isolates of B. fragilis (MICs = 0.5-5 μM) and various anaerobic bacteria when used at concentrations ranging from less than 0.1 to 3.2 μg/ml. It also inhibits the growth of Giardia isolates (IC50s = 0.01-0.47 μg/ml). Oral administration of ornidazole reduces T. vaginalis and T. foetus infection in mice and E. histolytica infection in rats with curative dose (CD50) values of 37, 3, and 10 mg/kg, respectively. Ornidazole (400 mg/kg per day) induces infertility in male rats within 7 days and inhibits spermatozoa binding to rat oocyte zona pellucida.
Chemical Properties
Crystalline Solid
Uses
Ornidazole is a drug that cures some protozoan infections. It has been investigated for use in Crohn's disease after bowel resection. It is indicated in treatment of mixed amoebiasis, mixed amoebic dysentery, mixed giardiasis, trichomoniasis, bacterial vaginosis, Sexually transmitted diseases, infections of gynaecology, lower respiratory tract infections, ENT, surgical and dental infections.
Definition
ChEBI: A C-nitro compound that is 5-nitroimidazole in which the hydrogens at positions 1 and 2 are replaced by 3-chloro-2-hydroxypropyl and methyl groups, respectively. It is used in the treatment of susceptible protozoal infections and for the treatment of anaerobic bacterial infections.
Pharmaceutical Applications
A 5-nitroimidazole available for oral administration, intravenous infusion and as a vaginal pessary. Its activity closely parallels that of metronidazole and tinidazole.
Peak plasma levels after a single 750 mg or 1.5 g oral dose reach 11 mg/L and 30 mg/L, respectively, within about 2 h. The half-life is 12–14 h. It is well absorbed from the vagina, with peak plasma concentrations of 5 mg/L being reached 12 h after the insertion of a 500 mg vaginal pessary. After a single 1 g intravenous infusion for colorectal surgery, serum levels reached about 24 mg/L after 15 min and about 6 mg/L after 24 h. It has wide tissue distribution, including CSF. Plasma protein binding is 10–15%.
It is metabolized in the liver, mainly to hydroxymethyl derivatives. The plasma clearance rate decreases in hepatic failure because of reduced liver metabolism and decreased biliary elimination. About 60% of an oral dose is recovered in the urine and 20% in the feces. The dosing interval should be doubled in patients with severe hepatic impairment, but it is unnecessary to reduce the dose in patients with impaired renal function. It is removed by hemodialysis.
Toxicity and side effects are similar to those of metronidazole and tinidazole and it has similar clinical uses. It has been shown to be effective for the prevention of recurrence of Crohn’s disease after ileocolonic resection.
Safety Profile
Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Experimental reproductive effects. Mutation data reported. Whenheated to decomposition it emits very toxic fumes of Clí and NOx.
Ornidazole Preparation Products And Raw materials
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
Organo Chem (India) | +91-8459110412 +91-9810846377 | Uttar Pradesh, India | 21 | 58 | Inquiry |
Saral Chemtech LLP | +91-9045505010 +91-9760958282 | Maharashtra, India | 12 | 58 | Inquiry |
Rivashaa Agrotech Biopharma Pvt. Ltd. | +91-26463395 +91-7926462688 | Gujarat, India | 1615 | 58 | Inquiry |
Besil Chem LLP | +91-7760252666 +91-9880731835 | Bangalore, India | 163 | 58 | Inquiry |
Anuja Healthcare Ltd | +91-6239597015 +91-9815004047 | Punjab, India | 26 | 58 | Inquiry |
Ralington Pharma | +91-7948911722 +91-9687771722 | Gujarat, India | 1350 | 58 | Inquiry |
Globela Industry Pvt Ltd | +91-2616158000 +91-9998199919 | Gujarat, India | 98 | 58 | Inquiry |
Unidrug Innovative Pharma Technologies Ltd | +91-7312533576 +91-7312533324 | Madhya Pradesh, India | 9 | 58 | Inquiry |
AARTIA KEM SCIENCE | +91-8291072530 +91-8291072530 | Maharashtra, India | 70 | 58 | Inquiry |
Biofil Chemicals and Pharmaceuticals Limited | +91-7312426700 +91-7312426713 | Madhya Pradesh, India | 12 | 58 | Inquiry |
Related articles
- Adverse Reactions to Ornidazole: Liver Damage and Fixed Drug Reactions
- Ornidazole can cause severe liver damage and fixed drug reactions, necessitating prompt recognition and withdrawal for appropr....
- Feb 6,2024
- Ornidazole:Uses,Mechanism,Dosage,Side effects
- Ornidazole is an antibiotic used to treat protozoan infections.A synthetic nitroimidazole, it is commercially obtained from an....
- Dec 29,2022
16773-42-5(Ornidazole)Related Search:
1of4
chevron_right